98 related articles for article (PubMed ID: 15071420)
1. Release of neuron-specific enolase and s100 after implantation of cardioverters/defibrillators.
Pelinka LE; Schmid-Hammer R; Redl H; Bahrami S
Crit Care Med; 2004 Apr; 32(4):1093-4. PubMed ID: 15071420
[No Abstract] [Full Text] [Related]
2. Release of neuron-specific enolase and S100 after implantation of cardioverters/defibrillators.
Dworschak M; Franz M; Czerny M; Gorlitzer M; Blaschek M; Grubhofer G; Haider W
Crit Care Med; 2003 Aug; 31(8):2085-9. PubMed ID: 12973163
[TBL] [Abstract][Full Text] [Related]
3. [Role of neuron specific enolase and S100 protein in evaluation of brain damage in patients resuscitated from cardiac arrest].
Miao WL; Li HL; Wang HD; Wang J; Liu H; Ren HX; Lin HY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Dec; 19(12):749-52. PubMed ID: 18093437
[TBL] [Abstract][Full Text] [Related]
4. Brain damage markers in children. Neurobiological and clinical aspects.
Leviton A; Dammann O
Acta Paediatr; 2002; 91(1):9-13. PubMed ID: 11883827
[TBL] [Abstract][Full Text] [Related]
5. Modeling serum biomarkers S100 beta and neuron-specific enolase as predictors of outcome after out-of-hospital cardiac arrest: an aid to clinical decision making.
Einav S; Kaufman N; Algur N; Kark JD
J Am Coll Cardiol; 2012 Jul; 60(4):304-11. PubMed ID: 22813607
[TBL] [Abstract][Full Text] [Related]
6. Outcome after cardiac arrest: predictive values and limitations of the neuroproteins neuron-specific enolase and protein S-100 and the Glasgow Coma Scale.
Pfeifer R; Börner A; Krack A; Sigusch HH; Surber R; Figulla HR
Resuscitation; 2005 Apr; 65(1):49-55. PubMed ID: 15797275
[TBL] [Abstract][Full Text] [Related]
7. Serum markers of brain damage and outcome prediction in patients after severe head injury.
Raabe A; Grolms C; Seifert V
Br J Neurosurg; 1999 Feb; 13(1):56-9. PubMed ID: 10492686
[TBL] [Abstract][Full Text] [Related]
8. We thank Dr. Pelinka and her colleagues for their interest in our investigation.
Dworschak M
Crit Care Med; 2004 Nov; 32(11):2367. PubMed ID: 15640668
[No Abstract] [Full Text] [Related]
9. Serum- and CSF-concentrations of brain specific proteins in hydrocephalus.
Beems T; Simons KS; Van Geel WJ; De Reus HP; Vos PE; Verbeek MM
Acta Neurochir (Wien); 2003 Jan; 145(1):37-43. PubMed ID: 12545260
[TBL] [Abstract][Full Text] [Related]
10. Serum S100B protein levels are correlated with subclinical neurocognitive declines after carotid endarterectomy.
Connolly ES; Winfree CJ; Rampersad A; Sharma R; Mack WJ; Mocco J; Solomon RA; Todd G; Quest DO; Stern Y; Heyer EJ
Neurosurgery; 2001 Nov; 49(5):1076-82; discussion 1082-3. PubMed ID: 11846900
[TBL] [Abstract][Full Text] [Related]
11. [Neuron-specific enolase in newborn infants with and without pathology].
Lechner W; Artner-Dworzak E; Zech J; Sidoroff A; Gedik A; Schoner W
Gynakol Geburtshilfliche Rundsch; 1992; 32 Suppl 1():156. PubMed ID: 1286335
[No Abstract] [Full Text] [Related]
12. S100 protein: its use as a marker of cerebral damage in cardiac operations.
Khan NE; De Souza AC; Pepper JR
Ann Thorac Surg; 2001 Aug; 72(2):666-7. PubMed ID: 11515935
[No Abstract] [Full Text] [Related]
13. [Diagnostic value of S-100 protein and neuron specific enolase as serum markers of cerebral disease following general anesthesia. Comment of the paper of U. Lindstedt et al. in Der Anaesthesist (2000) 49:887-892].
Woertgen C; Rothoerl RD
Anaesthesist; 2001 Jul; 50(7):529. PubMed ID: 11496693
[No Abstract] [Full Text] [Related]
14. Serum biomarkers for experimental acute spinal cord injury: rapid elevation of neuron-specific enolase and S-100 beta.
Marquardt G; Setzer M; Seifert V
Neurosurgery; 2006 Mar; 58(3):E590; author reply E590. PubMed ID: 16528168
[No Abstract] [Full Text] [Related]
15. Biochemical serum markers in head injury: an emphasis on clinical utility.
Mehta SS
Clin Neurosurg; 2010; 57():134-40. PubMed ID: 21280506
[No Abstract] [Full Text] [Related]
16. Assessment of serum S100B and neuron specific enolase levels to evaluate the neurotoxic effects of organic solvent exposure.
Sud P; Nelson LS; Fleming E; Fennell SL
Clin Toxicol (Phila); 2013 Dec; 51(10):1244. PubMed ID: 24138505
[No Abstract] [Full Text] [Related]
17. Predictive value of neuromarkers supported by a set of clinical criteria in patients with mild traumatic brain injury: S100B protein and neuron-specific enolase on trial: clinical article.
Wolf H; Frantal S; Pajenda GS; Salameh O; Widhalm H; Hajdu S; Sarahrudi K
J Neurosurg; 2013 Jun; 118(6):1298-303. PubMed ID: 23451906
[TBL] [Abstract][Full Text] [Related]
18. Influence of hemolysis on the measurement of S-100beta protein and neuron-specific enolase plasma concentrations during coronary artery bypass grafting.
Beaudeux JL; Léger P; Dequen L; Gandjbakhch I; Coriat P; Foglietti MJ
Clin Chem; 2000 Jul; 46(7):989-90. PubMed ID: 10894842
[No Abstract] [Full Text] [Related]
19. Prognostic value of somatosensory evoked potentials, neuron-specific enolase, and S100 for short-term outcome in ischemic stroke.
Haupt WF; Chopan G; Sobesky J; Liu WC; Dohmen C
J Neurophysiol; 2016 Mar; 115(3):1273-8. PubMed ID: 26745251
[TBL] [Abstract][Full Text] [Related]
20. Response to letter to the editor regarding "Assessment of serum S100B and neuron specific enolase levels to evaluate the neurotoxıc effects of organıc solvent exposure" in Clinical Toxicology 2013; (doi:10.3109/15563650.2013.820831).
Tutkun E; Yılmaz H; Yılmaz FM; Züngün C
Clin Toxicol (Phila); 2013 Dec; 51(10):1245. PubMed ID: 24138502
[No Abstract] [Full Text] [Related]
[Next] [New Search]
